EP0617288A2
Expired / Lapsed
EP
⏱️ 0.0 years remaining
Long emission wavelength chemiluminescent compounds and their use in test assays
Assignee: Novartis AG
•
Filing: 1994-03-18
•
Granted: —
•
Expires: 2014-03-18
Abstract
Abstract An assay method incorporating at least two different chemiluminescent compounds for detection and/or quantitation of at least two substances in a test sample is described. The synthesis of chemiluminescent reagents or conjugates for use in such methods as well as kits incorporating such reagents are also disclosed. The assays have particular application in the field of clinical diagnostics.
Inventors
- 👤 Say-Jong Law
- 👤 Qingping Jiang
- 👤 Walter Fischer
- 👤 John T. Unger
- 👤 Elizabeth K. Krodel
Bibliographic Details
Application Number
—
Jurisdiction
EP
Data Source
google_patents
Last Synchronized
2026-11-06 11:46
CPC Classifications
G; G01; G01N; G01N33/00; G01N33/48; G01N33/50; G01N33/58; G01N33/582; C; C07; C07D; C07D221/00; C07D221/02; C07D221/04; C07D221/18; C12; C12Q; C12Q1/00; C12Q1/68; C12Q1/6813; C12Q1/6816
Claims Analysis
Total Claims: 30
Claim 1
Independent Claim
69 words
A method for the detection and/or quantitation of at least two substances in a test sample characterised in that it comprises: simultaneously detecting the emission signals of at least two different chemiluminescent compounds, each chemiluminescent compound being associated with a substance in the test sample, the emission signals of each of the chemiluminescent compounds being discerned by the spectral emissions thereof so at to detect and/or quantitate the substances.
Claim 2
Dependent Claim
42 words
A method as claimed in claim 1 wherein each of the chemiluminescent compounds is conjugated to a binding partner which is specific for and binds to a substance to form a reaction product to be detected and/or quantitated in the test sample.
Claim 3
Dependent Claim
54 words
A method as claimed in claim 1 or claim 2 wherein the emission spectra of the chemiluminescent compounds or chemiluminescent conjugates are discernable in that the emission maxima thereof are spaced apart a sufficient distance to discern the signals of each conjugate, preferably the emission maxima are spaced greater than about 60 nanometers apart.
Claim 4
Independent Claim
27 words
A method as claimed in any of claims 1 to 3 wherein each of the emission spectra has a width of from about 100 to 250 nm.
Claim 5
Independent Claim
34 words
A method as claimed in any of claims 1 to 4 wherein an additional test substance may be introduced into the test sample, the added substance functioning as a control or an internal reference.
Claim 6
Independent Claim
24 words
A method as claimed in any of claims 1 to 5 wherein it is performed in a single reaction medium or a transfer tube.
Claim 7
Independent Claim
26 words
A method as claimed in any of claims 1 to 6 wherein it is useful for performing analytical assays including: industrial assays and clinical diagnostic assays.
Claim 8
Dependent Claim
20 words
A method as claimed in claim 7 wherein the assays comprise: immunoassays, homogeneous or heterogeneous, hybridization assays and amplification assays.
Claim 9
Independent Claim
40 words
A method as claimed in any of claims 1 to 8 wherein at least one chemiluminescent compound includes an aromatic ring fused acridinium compound or a benzacridinium ring system or an N-alkylated benzacridinium ring system or an acridinium ring system.
Claim 10
Independent Claim
88 words
A method for amplifying target sequences in a test sample characterised in that it comprises: (a) providing an optionally pretreated test sample suspected of containing one or more target sequences; (b) adding an internal reference or control to said test sample; (c) amplifying the target sequences; (d) providing at least two different chemiluminescent conjugates, each chemiluminescent conjugate being associated with a target sequence and the internal reference; and (e) simultaneously detecting and/or quantitating amplified target sequences and the internal reference by emissions of at least two chemiluminescent conjugates.
Claim 11
Dependent Claim
22 words
A method as claimed in claim 10 wherein the internal reference is a target sequence that either is or is not amplified.
Claim 12
Dependent Claim
38 words
A method as claimed in claim 10 or claim 11 wherein it further comprises performing at least one binding reaction, a hybridization reaction, specific to a target sequence of the test sample and/or specific to the internal reference.
Claim 13
Independent Claim
35 words
A method as claimed in any of claims 10 to 12 wherein at least one chemiluminescent compound includes an aromatic ring fused acridinium compound or an N-alkylated benzacridinium ring system or an acridinium ring system.
Claim 14
Dependent Claim
19 words
A chemiluminescent compound characterised in that, upon chemical treatment, it emits a blue-green, green, yellow, orange and red-orange light.
Claim 15
Dependent Claim
21 words
A compound as claimed in claim 14 wherein it has an emission spectra peak or maximum greater than about 515 nm.
Claim 16
Dependent Claim
30 words
A compound as claimed in claim 14 or claim 15 wherein it includes an aromatic ring fused acridinium compound or a benzacridinium ring system or an N-alkylated benzacridinium ring system.
Claim 17
Independent Claim
71 words
A method for amplifying target sequences in a test sample characterised in that it comprises: (a) providing a test sample suspected of containing one or more target sequences; (b) amplifying the target sequence(s); (c) providing at least two different chemiluminescent conjugates, each chemiluminescent conjugate being associated with a target sequence(s); (d) simultaneously detecting and/or quantitating amplified target sequences and any added internal reference by emissions of at least two chemiluminescent conjugates.
Claim 18
Dependent Claim
23 words
A method as claimed in claim 17 wherein at least one chemiluminescent compound includes a benzacridinium ring system or an acridinium ring system.
Claim 19
Dependent Claim
110 words
A chemiluminescent label assay method for detection and/or quantitating at least two substances in a test sample characterised in that it comprises: (a) providing a first chemiluminescent reagent to the test sample, said first chemiluminescent reagent including an aromatic ring fused acridinium compound or a benzacridinium ring system, preferably and N-alkylated benzacridinium ring system, and being specific to one substance in the test sample; (b) providing a second chemiluminescent reagent to the test sample, the second chemiluminescent reagent including an acridinium ring system and being specific to another substance in the test sample; and (c) activating the chemiluminescent reagents to provide discernable emission signals for detecting and/or quantitating the substances.
Claim 20
Dependent Claim
46 words
A method as claimed in claim 19 wherein it further comprises a binding step and wherein each chemiluminescent reagent further includes a conjugated molecule specific to a substance in the test sample to enable a binding reaction to occur so that a reaction product is formed.
Claim 21
Dependent Claim
46 words
A test kit for detecting and/or quantitating two or more substances in a test sample characterised in that it comprises at least two difference chemiluminescent compounds, each compound being conjugated to a binding partner which is specific for at least one substance in a test sample.
Claim 22
Dependent Claim
56 words
A test kit for performing a simultaneous assay on two or more substances in a test sample characterised in that it comprises: (a) a first chemiluminescent reagent including an aromatic ring fused acridinium system or a benzacridinium ring system, preferably an N-alkylated benzacridinium ring system; and (b) a second chemiluminescent reagent including an acridinium ring system.
Claim 23
Dependent Claim
41 words
A test kit for performing a simultaneous assay on two or more substances in a test sample characterised in that it comprises at least two different chemiluminescent reagents, each reagent having a discernable emission spectra for detecting and/or quantitating the substances.
Claim 24
Dependent Claim
34 words
A kit as claimed in claim 23 wherein at least one of the chemiluminescent reagents includes a N-alkylated benzacridinium ring system and/or at least one of the chemiluminescent reagents includes an acridinium ring system.
Claim 25
Dependent Claim
304 words
A luminescent compound characterised in that it corresponds to the following general formula: wherein W represents carbon; or C₇, W, C₉ or C₁₀ may be replaced with -N=; or W may be omitted and C₇ connected to C₉, and C₇, C₉ or C₁₀ may be replaced with -O-, -S-, -NH- or -NR-; Y and Y' independently represent alkyl which may contain up to 20 carbon atoms, optionally halogenated, or a polysubstituted aryl moiety corresponding to the following general formula: R₁ represents alkyl, alkenyl, alkynyl or aralkyl which may contain up to 20 heteroatoms; R₂, R₃, R₅, R₇, R₉ and R₁₀ independently represent hydrogen, optionally substituted aryl (ArR or Ar), halide, amino, hydroxyl, nitro, sulfonate, -R, -CN, -COOH, -SCN, -OR, -SR, -SSR, -C(O)R, -C(O)OR, -C(O)NHR, or -NHC(O)R; R₂ represents one or more substituents at C₁₋₄ or a fused aromatic ring with or without heteroatoms; R₃ represents one or more substituents at C₇, W, C₉ or C₁₀; A- represents a counter-ion preferably CH₃SO₄-, FSO₃-, CF₃SO₄-, C₄F₉SO₃-, CH₃C₆H₄SO₃- and halide; X represents a heteroatom, preferably nitrogen, oxygen or sulfur, such that, when X represents oxygen or sulfur, Z is omitted, and, when X represents nitrogen, Z represents -SO₂-Y'; R₄ and R₈ independently represent alkyl, alkenyl, alkynyl, alkoxyl, alkylthiol, or amido; R₆ represents -R₁₁-R₁₂, wherein R₁₁, if present, represents alkyl, optionally substituted aryl or aralkyl which may contain up to 20 heteroatoms; and R₁₂ represents a leaving group or an electrophilic functional group attached with a leaving group or -Q-R-Nu, -Q-R(I) n Nu, -Q-Nu, -R-Nu or -Nu; wherein n represents an integer of at least 1; Nu represents a nucleophilic group; Q represents a functional linkage; I represents an ionic or ionizable group; and R represents alkyl(ese), alkenyl(ese), alkynyl(ene), aryl(ene) or aralkyl(ene) which may contain up to 20 heteroatoms; R₅ and R₆, and R₆ and R₇ being interchangeable.
Claim 26
Dependent Claim
18 words
A compound as claimed in claim 25 wherein it is conjugated with a binding partner for assay use.
Claim 27
Dependent Claim
29 words
An intermediate characterised in that it is selected from; (a) benz[b]acridine-12-carboxylic acid hydrochloride; (b) 3-EtO-benz[b]acridinine-12-carboxylic acid; (c) 3-hydroxy-benz[b]acridine-12-carboxylic acid; (d) 2-MeO-benz[b]acridine-12-carboxylic acid; (e) 2-hydroxy-benz[b]acridine-12-carboxylic acid; (f) 3-MeO-acridine-9-carboxylic acid hydrochloride.
Claim 28
Dependent Claim
126 words
An intermediate characterised in that it corresponds to the following general formula: where W represents carbon; or C₇, W, C₉ or C₁₀ may be replaced with -N=, or W may be omitted and C₇ connected to C₉, and C₇, C₉ or C₁₀ may be replaced with -O-, -S-, -NH- or -NR-; R₂, R₃, R₉ and R₁₀ independently represent hydrogen, optionally substituted aryl (ArR or Ar), halide, amino, hydroxyl, nitro, sulfonate, -R, -CN, -COOH, -SCN, -OR, -SR, -SSR, -C(O)R, -C(O)OR, -C(O)NHR, or -NHC(O)R; R₂ represents one or more substituents at C₁₋₄ or a fused aromatic ring with or without heteroatoms; R₃ represents one or more substituents at C₇, W, C₉ or C₁₀; R represents alkyl(ene), alkenyl(ene), alkynyl(ene), aryl(ene) or aralkyl(ene) which may contain up to 20 heteroatoms.
Claim 29
Dependent Claim
275 words
An intermediate characterised in that it corresponds to the following general formula: where W represents carbon; or C₇, W, C₉ or C₁₀ may be replaced with -N=; or W may be omitted and C₇ connected to C₉ and C₇, C₉ or C₁₀ may be replaced with -O-, -S-, -NH- or -NR-; Y and Y' independently represent alkyl which may contain up to 20 carbon atoms, optionally halogenated, or a polysubstituted aryl moiety corresponding to the following general formula: R₂, R₃, R₉ and R₁₀ independently represent hydrogen, optionally substituted aryl (ArR or Ar), halide, amino, hydroxyl, nitro, sulfonate, -R, -CN, -COOH, -SCN, -OR, -SR, -SSR, -C(O)R, -C(O)OR, -C(O)NHR, or NHC(O)R; R₂ represents one or more substituents at C₁₋₄ or a fused aromatic ring with or without heteroatoms; R₃ represents one or more substituents at C₇, W, C₉ or C₁₀; X represents a heteroatom, preferably nitrogen, oxygen or sulfur, such that, when X represents oxygen or sulfur, Z is omitted, and, when X represents nitrogen, Z represents -SO₂-Y'; R₄ and R₈ independently represent alkyl, alkenyl, alkynyl, alkoxyl, alkylthiol or amido; R₆ represents -R₁₁-R₁₂, wherein R₁₁, if present, represents alkyl, optionally substituted aryl or aralkyl which may contain up to 20 heteroatoms; and R₁₂ represents a leaving group or an electrophilic functional group attached with a leaving group or -Q-R-Nu, -Q-R(I) n Nu, -Q-Nu, -R-Nu or Nu; wherein n represents an integer of at least 1; Nu represents a nucleophilic group; Q represents a functional linkage; I represents an ionic or ionizable group; and R represents alkyl(ese), alkenyl(ene), alkynyl(ene), aryl(ene) or aralkyl(ene) which may contain up to 20 heteroatoms; R₅ and R₆, and R₆ and R₇ being interchangeable.
Claim 30
Dependent Claim
21 words
A compound as claimed in claim 25 wherein the isomeric, furano, thiopheno, pyrro and pyrido moiety rings include substituent(s) comprising R₃.
References Cited (Backward Citations)
No citation records indexed.
USPTO Annuity & Maintenance Windows
Maintenance schedule is calculated for granted US utility patents.